(H4Z3) HSBC MSCI Emerging Markets - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000KCS7J59

Etf: Etf, Tracker, Acc, Emerging

Total Rating 60
Risk 83
Buy Signal -0.15
Risk 5d forecast
Volatility 13.6%
Relative Tail Risk -4.23%
Reward TTM
Sharpe Ratio 1.21
Alpha 18.35
Character TTM
Beta 0.224
Beta Downside 0.473
Drawdowns 3y
Max DD 18.86%
CAGR/Max DD 0.73

Description: H4Z3 HSBC MSCI Emerging Markets January 12, 2026

The HSBC MSCI Emerging Markets UCITS ETF (USD Acc EUR), ticker H4Z3, is a Germany-domiciled exchange-traded fund that provides investors with exposure to the broad MSCI Emerging Markets Total Market Index (Net Return, USD). It falls under the Global Emerging Markets Equity category and seeks to replicate the index’s performance on a total-return basis, reinvesting dividends.

Key metrics as of the latest reporting period include an expense ratio of 0.15%, assets under management of roughly €2.5 billion, and a top-10 holding concentration of about 12%, dominated by Chinese technology and financial firms such as Tencent and Ping An. The fund’s sector tilt leans toward information technology (≈22% of assets) and financials (≈18%), reflecting the ongoing growth in digital services and banking reforms across emerging economies. Macro drivers that typically influence performance are commodity price cycles, especially in energy and metals, and the pace of monetary policy normalization in major advanced economies, which affect capital flows into emerging markets.

For a deeper, data-driven look at how this ETF fits into a diversified portfolio, you might explore the analytics on ValueRay.

What is the price of H4Z3 shares?

As of February 05, 2026, the stock is trading at EUR 14.05 with a total of 146,502 shares traded.
Over the past week, the price has changed by +0.78%, over one month by +4.46%, over three months by +6.46% and over the past year by +26.14%.

Is H4Z3 a buy, sell or hold?

HSBC MSCI Emerging Markets has no consensus analysts rating.

What are the forecasts/targets for the H4Z3 price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 15.7 11.5%

H4Z3 Fundamental Data Overview February 03, 2026

Market Cap USD = 3.13b (2.64b EUR * 1.1854 EUR.USD)
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.64b EUR (2.64b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.64b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.64b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.74% (E(2.64b)/V(2.64b) * Re(6.74%) + (debt-free company))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for H4Z3 ETF

Fund Manager Positions: Dataroma | Stockcircle